Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥8,547 | CN¥8,824 | CN¥13,039 | CN¥9,987 |
| % Growth | -3.1% | -32.3% | 30.6% | – |
| Cost of Goods Sold | CN¥8,010 | CN¥6,823 | CN¥7,492 | CN¥5,874 |
| Gross Profit | CN¥537 | CN¥2,001 | CN¥5,547 | CN¥4,113 |
| % Margin | 6.3% | 22.7% | 42.5% | 41.2% |
| R&D Expenses | CN¥31 | CN¥47 | CN¥68 | CN¥33 |
| G&A Expenses | CN¥402 | CN¥387 | CN¥804 | CN¥282 |
| SG&A Expenses | CN¥482 | CN¥446 | CN¥856 | CN¥334 |
| Sales & Mktg Exp. | CN¥79 | CN¥60 | CN¥52 | CN¥52 |
| Other Operating Expenses | CN¥87 | -CN¥35 | CN¥142 | CN¥155 |
| Operating Expenses | CN¥599 | CN¥459 | CN¥1,066 | CN¥522 |
| Operating Income | -CN¥62 | CN¥1,542 | CN¥4,481 | CN¥3,591 |
| % Margin | -0.7% | 17.5% | 34.4% | 36% |
| Other Income/Exp. Net | -CN¥4 | -CN¥6 | -CN¥3 | -CN¥13 |
| Pre-Tax Income | -CN¥66 | CN¥1,536 | CN¥4,479 | CN¥3,578 |
| Tax Expense | CN¥5 | CN¥257 | CN¥668 | CN¥552 |
| Net Income | CN¥31 | CN¥1,283 | CN¥3,807 | CN¥3,018 |
| % Margin | 0.4% | 14.5% | 29.2% | 30.2% |
| EPS | 0.004 | 0.147 | 0.438 | 0.358 |
| % Growth | -97.4% | -66.3% | 22.3% | – |
| EPS Diluted | 0.004 | 0.147 | 0.438 | 0.358 |
| Weighted Avg Shares Out | 8,280 | 8,706 | 8,697 | 8,436 |
| Weighted Avg Shares Out Dil | 8,504 | 8,706 | 8,697 | 8,436 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥47 | CN¥60 | CN¥23 | CN¥9 |
| Interest Expense | CN¥67 | CN¥29 | CN¥52 | CN¥79 |
| Depreciation & Amortization | CN¥975 | CN¥988 | CN¥915 | CN¥631 |
| EBITDA | CN¥924 | CN¥2,410 | CN¥5,400 | CN¥4,282 |
| % Margin | 10.8% | 27.3% | 41.4% | 42.9% |